These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7673774)

  • 1. Respiratory depression in a patient receiving oral methadone for cancer pain.
    Hunt G; Bruera E
    J Pain Symptom Manage; 1995 Jul; 10(5):401-4. PubMed ID: 7673774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain.
    Bruera E; Watanabe S; Fainsinger RL; Spachynski K; Suarez-Almazor M; Inturrisi C
    Pain; 1995 Aug; 62(2):141-146. PubMed ID: 8545138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on the clinical use of methadone for cancer pain.
    Ripamonti C; Zecca E; Bruera E
    Pain; 1997 Apr; 70(2-3):109-15. PubMed ID: 9150283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory depression during methadone rotation in a patient with advanced cancer.
    Oneschuk D; Bruera E
    J Palliat Care; 2000; 16(2):50-4. PubMed ID: 10887733
    [No Abstract]   [Full Text] [Related]  

  • 5. Patient-controlled analgesia with oral methadone in cancer pain: preliminary report.
    Mercadante S; Sapio M; Serretta R; Caligara M
    Ann Oncol; 1996 Aug; 7(6):613-7. PubMed ID: 8879376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid rotation in patients with cancer pain. A retrospective comparison of dose ratios between methadone, hydromorphone, and morphine.
    Bruera E; Pereira J; Watanabe S; Belzile M; Kuehn N; Hanson J
    Cancer; 1996 Aug; 78(4):852-7. PubMed ID: 8756381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion from parenteral to oral methadone.
    González-Barboteo J; Porta-Sales J; Sánchez D; Tuca A; Gómez-Batiste X
    J Pain Palliat Care Pharmacother; 2008; 22(3):200-5. PubMed ID: 19042849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone versus morphine as a first-line strong opioid for cancer pain: a randomized, double-blind study.
    Bruera E; Palmer JL; Bosnjak S; Rico MA; Moyano J; Sweeney C; Strasser F; Willey J; Bertolino M; Mathias C; Spruyt O; Fisch MJ
    J Clin Oncol; 2004 Jan; 22(1):185-92. PubMed ID: 14701781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent subcutaneous methadone administration in the management of cancer pain.
    Centeno C; Vara F
    J Pain Palliat Care Pharmacother; 2005; 19(2):7-12. PubMed ID: 16061456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio?
    Ripamonti C; Groff L; Brunelli C; Polastri D; Stavrakis A; De Conno F
    J Clin Oncol; 1998 Oct; 16(10):3216-21. PubMed ID: 9779694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose ratio between morphine and methadone in patients with cancer pain: a retrospective study.
    Lawlor PG; Turner KS; Hanson J; Bruera ED
    Cancer; 1998 Mar; 82(6):1167-73. PubMed ID: 9506365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to switch from morphine or oxycodone to methadone in cancer patients? a randomised clinical phase II trial.
    Moksnes K; Dale O; Rosland JH; Paulsen O; Klepstad P; Kaasa S
    Eur J Cancer; 2011 Nov; 47(16):2463-70. PubMed ID: 21775131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching from methadone to a different opioid: what is the equianalgesic dose ratio?
    Walker PW; Palla S; Pei BL; Kaur G; Zhang K; Hanohano J; Munsell M; Bruera E
    J Palliat Med; 2008 Oct; 11(8):1103-8. PubMed ID: 18980450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid switching between transdermal fentanyl and methadone in cancer patients.
    Mercadante S; Ferrera P; Villari P; Casuccio A
    J Clin Oncol; 2005 Aug; 23(22):5229-34. PubMed ID: 16051965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotation to methadone after opioid dose escalation: How should individualization of dosing occur?
    Zimmermann C; Seccareccia D; Booth CM; Cottrell W
    J Pain Palliat Care Pharmacother; 2005; 19(2):25-31. PubMed ID: 16061458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone for cancer pain: what have we learned from clinical studies?
    Soares LG
    Am J Hosp Palliat Care; 2005; 22(3):223-7. PubMed ID: 15909785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capsules and suppositories of methadone for patients on high-dose opioids for cancer pain: clinical and economic considerations.
    Watanabe S; Belzile M; Kuehn N; Hanson J; Bruera E
    Cancer Treat Rev; 1996 Jan; 22 Suppl A():131-6. PubMed ID: 8625339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the early pharmacodynamic profile of oral methadone for cancer-related breakthrough pain: a pilot study.
    Fisher K; Stiles C; Hagen NA
    J Pain Symptom Manage; 2004 Dec; 28(6):619-25. PubMed ID: 15589088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.